Suppr超能文献

壶腹癌根治性切除术后失败的模式及预测因素。

Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater.

作者信息

Todoroki Takeshi, Koike Naoto, Morishita Yukio, Kawamoto Toru, Ohkohchi Nobuhiro, Shoda Junichi, Fukuda Yoshiharu, Takahashi Hideto

机构信息

Departments of Surgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-Shi, Japan.

出版信息

Ann Surg Oncol. 2003 Dec;10(10):1176-83. doi: 10.1245/aso.2003.07.512.

Abstract

BACKGROUND

Curative resection does not always equate with long-term survival. The aim was to identify patterns and predictors of failure and independent factors of prognosis after curative resection.

METHODS

Sixty-six patients with ampullary carcinoma who underwent surgical intervention were reviewed. Fifty-nine patients underwent pancreaticoduodenectomy. Cox regression analysis, log-rank test, Fisher exact test, or chi(2) test was used.

RESULTS

No patient died as a result of surgery; major complications occurred in three, and the 5-year survival rate after curative resection (n = 55) was 52.6%. Significant survival predictors were preoperative serum carcinoembryonic antigen level; gross tumor appearance; tumor, node, and tumor node metastasis stage; and microscopic lymphatic vessel and venous invasion in the primary tumor. Multivariate analysis demonstrated that lymphatic vessel invasion, tumor, and tumor node metastasis stage were significant independent prognostic factors. No patient experienced locoregional failure alone; all 24 relapsed patients had distant failure, and six of them had both. The liver was the most frequent metastatic organ, followed by nodes, peritoneum, lung, and bone. The carcinoembryonic antigen and carbohydrate antigen levels and lymphatic vessel and venous invasion were significant predictors of distant failure, and the mean time to relapse was 13 (range, 0.7-33) months.

CONCLUSIONS

Curative resection is associated with significant survival; however, effective systemic adjuvant therapy is needed to prevent distant failure for patients with elevated carcinoembryonic antigen and carbohydrate antigen levels or positive lymphatic vessel or venous invasion. A 3-year follow-up period would be necessary to document relapses.

摘要

背景

根治性切除并不总是等同于长期生存。目的是确定根治性切除术后失败的模式和预测因素以及预后的独立因素。

方法

回顾了66例行手术干预的壶腹癌患者。59例患者接受了胰十二指肠切除术。采用Cox回归分析、对数秩检验、Fisher精确检验或卡方检验。

结果

无患者因手术死亡;3例发生严重并发症,根治性切除术后(n = 55)的5年生存率为52.6%。显著的生存预测因素是术前血清癌胚抗原水平;大体肿瘤外观;肿瘤、淋巴结和远处转移分期;以及原发肿瘤的显微镜下淋巴管和静脉侵犯。多因素分析表明,淋巴管侵犯、肿瘤和远处转移分期是显著的独立预后因素。无患者单独发生局部区域失败;所有24例复发患者均有远处转移,其中6例两者都有。肝脏是最常见的转移器官,其次是淋巴结、腹膜、肺和骨。癌胚抗原和糖类抗原水平以及淋巴管和静脉侵犯是远处转移的显著预测因素,复发的平均时间为13(范围0.7 - 33)个月。

结论

根治性切除与显著的生存率相关;然而,对于癌胚抗原和糖类抗原水平升高或淋巴管或静脉侵犯阳性的患者,需要有效的全身辅助治疗以预防远处转移。需要3年的随访期来记录复发情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验